We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bristol-Myers

News List

Bristol-Myers puts up Opdivo-plus-Yervoy data, adding to combo-therapy mystery fiercepharma
August 17, 2017
Opdivo, a PD-1 checkpoint inhibitor, and its fellow Bristol-Myers immunotherapy Yervoy are in testing in a variety of cancers, and analysts are watching to see if combining a PD-1 med with a CTLA4 therapy beats out PD-1/L1 chemo combos.
China’s Zai Lab files for $115M Nasdaq IPO to take Tesaro, Bristol-Myers cancer drugs through late-p fiercebiotech
August 17, 2017
A slice of the Zai Lab IPO haul is earmarked for trials of Tesaro's niraparib.
Bristol-Myers sells clinical manufacturing facility to Seattle Genetics fiercepharma
August 07, 2017
Bristol-Myers Squibb is unloading a clinical materials manufacturing facility and labs in Washington to Seattle Genetics, which has agreed to keep on the workers employed there.
Bristol-Myers to buy IFM Therapeutics expressbpd
August 07, 2017
Bristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million

Previous page 1 2 3 4 5 Next page